Case report shows successful treatment of bacteremia in a low-birth-weight infant, suggesting daptomycin's effectiveness.
We report a successful case of treatment with daptomycin (DAP) in an extremely low-birth-weight infant presenting with persistent bacteremia caused by methicillin-resistant Staphylococcus epidermidis (MRSE).
No takes yet. Share an insight, caveat, or question.
Nagaoka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: